CorVista Health Completes $65 Million Series C Equity Raise Bringing Total Funding to Nearly $100 Million. Read more.

Transforming healthcare and improving the patient experience through our novel cardiac diagnostic platform

The CorVista® System is a next-generation, non-invasive cardiac diagnostic platform combining advanced disciplines of mathematics and physics with machine learning to reshape existing care pathways.

The CorVista® System is a next-generation, non-invasive cardiac diagnostic platform combining advanced disciplines of mathematics and physics with machine learning to reshape existing care pathways.

RADIATION-FREE,
CARDIAC STRESS-FREE

Evaluates cardiovascular anomalies without the typical patient burden of traditional stress testing

Delivers predictive assessments on cardiovascular disease

POINT-OF-CARE
RESULTS

Allows for patient procedure and consultation with clinician, who will have results available at her or his fingertips, in a single office visit

Enables rapid diagnosis, connecting patients to appropriate treatments more quickly

TRULY DIGITAL

Collects patient signals on simple, hand-held digital instrument

Uses powerful machine-learned algorithms to generate results, all run on the cloud

Slider

The CorVista System has the potential to change the way cardiovascular disease is diagnosed by providing patients and clinicians with valuable insights in a single office visit.

Signal Acquisition.

Signals naturally emitted by the heart are collected while the patient is at rest.

Data Upload.

Patient data is automatically transferred to the System’s cloud-based, secure database.

Analytical Engine.

Complex mathematical manipulations are performed on patient data, and proprietary machine-learned algorithms generate results on the presence of cardiovascular disease.

Clinical Consultation.

Test results are available to clinicians in a secure, web portal shortly after the procedure is completed.

Caution—Investigational Device. Limited by Federal Law to Investigational Use. The CorVista® System is not available for commercial distribution.

Slider

Using machine learning, the CorVista System has the potential to noninvasively diagnose multiple cardiovascular conditions.

Coronary Artery
Disease

Pulmonary
Hypertension

Heart Failure